Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Journal of Crohn'S & Colitis
|
December 22, 2010
Why does Crohn's disease usually occur in terminal ileum?
Renzo Caprilli
Biologics : Targets & Therapy
|
August 27, 2009
Natalizumab in the treatment of Crohn's disease
Danila Guagnozzi, Renzo Caprilli
Expert Review of Clinical Immunology
|
July 3, 2010
Advances in the pathogenesis of inflammatory bowel diseases: Capri 2010
Renzo Caprilli, Giovanni Latella, Giuseppe Frieri
Inflammatory Bowel Diseases
|
February 20, 2007
Late-breaking news from the "4th International Meeting on Inflammatory Bowel Diseases" Capri, 2006
Giovanni Latella, Claudio Fiocchi, Renzo Caprilli
Digestive Diseases (Basel, Switzerland)
|
September 11, 2007
Medical therapy for Crohn's disease: top-down or step-up?
Filip Baert, Renzo Caprilli, Erika Angelucci
Journal of Crohn'S & Colitis
|
December 22, 2010
Historical evolution of the management of severe ulcerative colitis
Renzo Caprilli, Valeria Clemente, Giuseppe Frieri
Nature Clinical Practice. Gastroenterology & Hepatology
|
February 3, 2007
Current management of severe ulcerative colitis
Renzo Caprilli, Angelo Viscido, Giovanni Latella
Journal of Crohn'S & Colitis
|
December 3, 2010
Eating the enemy in Crohn's disease: an old theory revisited
Renzo Caprilli, Pierre Lapaquette, Arlette Darfeuille-Michaud
Medicinal Research Reviews
|
April 28, 2007
Biological agents for ulcerative colitis: hypes and hopes
Silvio Danese, Erika Angelucci, Alberto Malesci, et al.
Journal of Crohn'S & Colitis
|
December 22, 2010
The long journey of salicylates in ulcerative colitis: The past and the future
Renzo Caprilli, Monica Cesarini, Erika Angelucci, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Journal of Crohn'S & Colitis
|
December 22, 2010
Why does Crohn's disease usually occur in terminal ileum?
Renzo Caprilli
Biologics : Targets & Therapy
|
August 27, 2009
Natalizumab in the treatment of Crohn's disease
Danila Guagnozzi, Renzo Caprilli
Expert Review of Clinical Immunology
|
July 3, 2010
Advances in the pathogenesis of inflammatory bowel diseases: Capri 2010
Renzo Caprilli, Giovanni Latella, Giuseppe Frieri
Inflammatory Bowel Diseases
|
February 20, 2007
Late-breaking news from the "4th International Meeting on Inflammatory Bowel Diseases" Capri, 2006
Giovanni Latella, Claudio Fiocchi, Renzo Caprilli
Digestive Diseases (Basel, Switzerland)
|
September 11, 2007
Medical therapy for Crohn's disease: top-down or step-up?
Filip Baert, Renzo Caprilli, Erika Angelucci
Journal of Crohn'S & Colitis
|
December 22, 2010
Historical evolution of the management of severe ulcerative colitis
Renzo Caprilli, Valeria Clemente, Giuseppe Frieri
Nature Clinical Practice. Gastroenterology & Hepatology
|
February 3, 2007
Current management of severe ulcerative colitis
Renzo Caprilli, Angelo Viscido, Giovanni Latella
Journal of Crohn'S & Colitis
|
December 3, 2010
Eating the enemy in Crohn's disease: an old theory revisited
Renzo Caprilli, Pierre Lapaquette, Arlette Darfeuille-Michaud
Medicinal Research Reviews
|
April 28, 2007
Biological agents for ulcerative colitis: hypes and hopes
Silvio Danese, Erika Angelucci, Alberto Malesci, et al.
Journal of Crohn'S & Colitis
|
December 22, 2010
The long journey of salicylates in ulcerative colitis: The past and the future
Renzo Caprilli, Monica Cesarini, Erika Angelucci, et al.
Page
of 3